What Is the Best Surgical Margin for a Basal Cell Carcinoma: A Meta-Analysis of the Literature

被引:131
作者
Gulleth, Yusuf
Goldberg, Nelson
Silverman, Ronald P.
Gastman, Brian R. [1 ]
机构
[1] Univ Maryland, Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Baltimore, MD 21201 USA
关键词
MOHS MICROGRAPHIC SURGERY; NONMELANOMA SKIN CANCERS; MICROSCOPICALLY CONTROLLED EXCISION; FROZEN-SECTION CONTROL; 5-YEAR FOLLOW-UP; INCOMPLETE EXCISION; PERIOCULAR BASAL; CLINICAL-FEATURES; BIOLOGIC BEHAVIOR; POSITIVE MARGINS;
D O I
10.1097/PRS.0b013e3181ea450d
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Current management of basal cell carcinoma is surgical excision. Most resections use predetermined surgical margins. The basis of ideal resection margins is almost completely from retrospective data and mainly from small case series. This article presents a systematic analysis from a large pool of data to provide a better basis of determining ideal surgical margin. Methods: A systematic analysis was performed on data from 89 articles from a larger group of 973 articles selected from the PubMed database. Relevant inclusion and exclusion criteria were applied to all articles reviewed and the data were entered into a database for statistical analysis. Results: The total number of lesions analyzed was 16,066; size ranged from 3 to 30 mm (mean, 11.7 +/- 5.9 mm). Surgical margins ranged from 1 to 10 mm (mean, 3.9 +/- 1.4 mm). Negative surgical margins ranged 45 to 100 percent (mean, 86 +/- 12 percent). Recurrence rates for 5-, 4-, 3-, and 2-mm surgical margins were 0.39, 1.62, 2.56, and 3.96 percent, respectively. Pooled data for incompletely excised margins have an average recurrence rate of 27 percent. Conclusions: A 3-mm surgical margin can be safely used for nonmorpheaform basal cell carcinoma to attain 95 percent cure rates for lesions 2 cm or smaller. A positive pathologic margin has an average recurrence rate of 27 percent. (Plast. Reconstr. Surg. 126: 1222, 2010.)
引用
收藏
页码:1222 / 1231
页数:10
相关论文
共 106 条
  • [1] ALBRIGHT SD, 1982, J AM ACAD DERMATOL, V21, P223
  • [2] Basal cell carcinoma of the face: Surgery or radiotherapy? Results of a randomized study
    Avril, MF
    Auperin, A
    Margulis, A
    Gerbaulet, A
    Duvillard, P
    Benhamou, E
    Guillaume, JC
    Chalon, R
    Petit, JY
    SanchoGarnier, H
    Prade, M
    Bouzy, J
    Chassagne, D
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (01) : 100 - 106
  • [3] SCALPEL EXCISION OF BASAL-CELL CARCINOMAS
    BART, RS
    SCHRAGER, D
    KOPF, AW
    BROMBERG, J
    DUBIN, N
    [J]. ARCHIVES OF DERMATOLOGY, 1978, 114 (05) : 739 - 742
  • [4] The significance of tumor persistence after incomplete excision of basal cell carcinoma
    Berlin, J
    Katz, KH
    Helm, KF
    Maloney, ME
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 549 - 553
  • [5] Factors affecting incomplete excision of nonmelanoma skin cancers in New Zealand
    Bhatti, Asif Zubair
    Asif, Saima
    Alwan, Majeed
    [J]. ANNALS OF PLASTIC SURGERY, 2006, 57 (05) : 513 - 516
  • [6] THE USE OF MOHS MICROGRAPHIC SURGERY FOR DETERMINATION OF RESIDUAL TUMOR IN INCOMPLETELY EXCISED BASAL-CELL CARCINOMA
    BIELEY, HC
    KIRSNER, RS
    REYES, BA
    GARLAND, LD
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (05) : 754 - 756
  • [7] Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins
    Bisson, MA
    Dunkin, CSJ
    Suvarna, SK
    Griffiths, RW
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 2002, 55 (04): : 293 - 297
  • [8] SURGICAL RESULTS IN 477 BASAL-CELL CARCINOMAS
    BLOMQVIST, G
    ERIKSSON, E
    LAURITZEN, C
    [J]. SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 1982, 16 (03): : 283 - 285
  • [9] Risk factors for incomplete excision of basal cell carcinomas
    Bogdanov-Berezovsky, A
    Cohen, AD
    Glesinger, R
    Cagnano, E
    Krieger, Y
    Rosenberg, L
    [J]. ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 44 - 47
  • [10] Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis
    Boztepe, G
    Hohenleutner, S
    Landthaler, M
    Hohenleutner, U
    [J]. ACTA DERMATO-VENEREOLOGICA, 2004, 84 (03) : 218 - 222